Recent studies have found that SNRPD2 and SNRPD3, as RNA splicing factors, can inhibit the proliferation of breast cancer cells and laryngeal squamous carcinoma cells and participate in the study of cell cycle-related mechanisms during early fracture [24, 25]. The gene discussed is SNRPD2; the disease is breast carcinoma.